YOLFTbeta
Photocure

Photocure

PHO · OL · Healthcare / Drug Manufacturers - Specialty & Generic

42.85NOK+0.95 (+2.27%)

Price History

Full chart

Market Stats

Previous Close41.90
Open41.50
Day Range41.50 – 43.20
52-Week Range46.25 – 79.80
Volume75.71K
Market Cap1.29B
P/E (TTM)16.53
Forward P/E121.95
EPS2.91
Dividend Yield0.00%
Beta0.32
50-Day Avg52.83
200-Day Avg61.85

About

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through two segments, Commercial Franchise and Development Portfolio. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It is also developing Cevira, a photodynamic drug-device combination product candidate for the non-surgical treatment of high-grade cervical dysplasia. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreement with Richard Wolf GmbH to develop and commercialize a 4K LED high-definition reusable blue light cystoscope based on Richard Wolf's System blue technology. It sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. It has partnership with Artera for digital pathology AI test evaluation for bladder cancer. The company operates in the Nordic countries, Germany, France, Austria, the United Kingdom, the Benelux, Italy, other European countries, Canada, and the United States. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Daniel Schneider
  • Employees99
  • HeadquartersHoffsveien 4, Oslo, Norway, 0275, Norway
  • Websitehttps://www.photocure.com

Leadership

  • Mr. Daniel SchneiderPresident, CEO & Acting CFO
  • Anja Gossens-von der HeidtHead of Global Human Resources
  • Dr. Anders Neijber M.D.Chief Medical Officer of Global Medical Affairs, Clinical Development and R&D
  • Jane HealyVice President & General Manager of Europe
  • Mr. Priyam Shah????Vice President of Investor Relations
  • Mr. Tolv HillestadGroup Controller
  • Mr. Dick PetersVice President of Finance & IT

Financials

Income Statement

Currency: NOK2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.13M2.33M25.22M55.15M77.81M53.64M210.32M99.01M102.22M48.43M177.36M115.57M133.82M83.62M128.95M134.72M143.63M150.91M181.51M281.56M256.48M360.54M393.13M500.66M525.39M532.58M
Growth (%)-+9.34%+982.53%+118.67%+41.08%-31.06%+292.09%-52.93%+3.25%-52.62%+266.23%-34.84%+15.80%-37.52%+54.22%+4.47%+6.61%+5.07%+20.28%+55.12%-8.91%+40.57%+9.04%+27.35%+4.94%+1.37%
Cost of Revenue--5.83M9.51M13.07M13.43M22.25M17.33M19.07M5.54M9.12M11.07M9.40M6.83M7.00M8.22M9.34M12.01M17.15M22.51M18.51M24.05M22.70M26.14M30.72M41.99M
Gross Profit--19.39M45.64M64.74M40.21M188.07M81.68M83.15M42.89M168.23M104.50M124.42M76.79M121.96M126.50M134.29M138.90M164.36M259.04M237.97M336.49M370.44M474.52M494.67M490.59M
Gross Margin--76.88%82.75%83.21%74.96%89.42%82.50%81.34%88.56%94.86%90.42%92.97%91.83%94.57%93.90%93.50%92.04%90.55%92.00%92.78%93.33%94.23%94.78%94.15%92.12%
Operating Expense--128.92M99.30M105.60M87.46M109.73M169.13M150.52M121.84M160.71M161.87M163.67M148.63M127.59M148.48M150.15M184.10M202.26M216.31M251.31M327.10M419.44M446.71M474.27M491.33M
Operating Income---109.53M-53.66M-40.86M-47.25M78.34M-87.45M-67.37M-78.95M7.52M-57.37M-39.25M-71.85M-5.63M-21.99M-15.86M-45.20M-37.90M42.74M-13.34M9.39M-49.00M27.81M20.40M-745.00K
Operating Margin---434.23%-97.28%-52.51%-88.09%37.25%-88.33%-65.91%-163.03%4.24%-49.64%-29.33%-85.92%-4.37%-16.32%-11.04%-29.95%-20.88%15.18%-5.20%2.60%-12.46%5.55%3.88%-0.14%
EBITDA---108.26M-51.98M-48.29M-52.52M80.41M-86.06M-46.73M-61.50M23.99M-43.96M-29.40M-61.69M3.00M-8.79M-35.29M-33.09M3.71M58.95M5.95M33.52M-20.19M63.75M65.22M37.45M
EBITDA Margin---429.20%-94.24%-62.06%-97.91%38.23%-86.93%-45.71%-126.99%13.52%-38.04%-21.97%-73.78%2.33%-6.53%-24.57%-21.93%2.04%20.94%2.32%9.30%-5.14%12.73%12.41%7.03%
Net Income---96.00M-42.77M-45.03M-38.21M85.08M-74.97M-64.38M312.38M18.09M-7.51M-47.90M-58.95M-24.70M-36.18M35.31M-34.70M-36.71M31.83M-22.40M-30.90M-71.86M979.00K-3.34M-1.52M
Net Income Margin---380.62%-77.54%-57.87%-71.23%40.45%-75.72%-62.98%645.04%10.20%-6.50%-35.79%-70.50%-19.15%-26.85%24.58%-22.99%-20.22%11.31%-8.73%-8.57%-18.28%0.20%-0.64%-0.29%
R&D42.30M78.04M77.30M38.40M31.72M38.24M38.20M112.10M84.30M78.98M90.17M66.19M50.08M33.98M32.55M31.34M22.96M32.59M19.14M13.64M13.84M4.32M3.34M2.07M3.63M402.00K
R&D as % of Total Revenue1984.94%3349.18%306.47%69.62%40.76%71.29%18.16%113.22%82.47%163.09%50.84%57.28%37.42%40.63%25.25%23.26%15.99%21.60%10.55%4.85%5.40%1.20%0.85%0.41%0.69%0.08%
Interest Expense0000103.00K66.00K36.00K016.10M13.55M4.58M2.36M5.00K10.00K3.00K000007.03M23.83M25.80M26.33M28.03M33.58M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.13%0.12%0.02%0.00%15.75%27.98%2.58%2.05%0.00%0.01%0.00%0.00%0.00%0.00%0.00%0.00%2.74%6.61%6.56%5.26%5.34%6.31%

Balance Sheet

Currency: NOK2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets404.85M319.57M299.01M233.40M173.71M105.70M375.42M301.39M237.85M456.86M513.84M509.18M432.98M301.73M270.58M248.06M285.85M263.10M231.20M257.35M776.05M789.65M719.03M711.97M739.09M707.06M
Total Liabilities47.49M60.17M132.01M101.50M88.14M57.24M48.49M41.40M38.15M41.08M54.99M69.85M52.71M32.60M30.52M38.00M33.91M45.02M54.85M48.76M267.92M287.01M256.30M229.13M237.37M222.83M
Total Equity357.36M259.40M167.00M130.99M85.40M48.47M326.94M259.01M199.69M415.78M458.85M439.34M380.27M269.12M240.06M210.06M251.94M218.08M176.34M208.59M508.13M502.63M462.73M482.85M501.72M484.23M
Cash30.74M19.69M34.09M15.54M137.95M72.33M335.09M252.45M179.90M403.50M389.24M355.18M298.57M163.23M161.25M129.95M165.33M125.30M102.50M121.20M329.53M319.04M264.65M256.34M288.83M238.89M
Total Debt-------------------6.95M53.89M67.14M39.54M---
Net Debt---34.09M-15.54M-137.95M-72.33M-335.09M-252.45M-179.90M-403.50M-389.24M-355.18M-298.57M-163.23M-161.25M-129.95M-165.33M-125.30M-102.50M-114.25M-275.64M-251.90M-225.11M---

Cash Flow

Currency: NOK2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---50.91M-70.51M-50.25M-70.54M66.33M-95.66M-59.68M317.44M15.60M-34.47M-54.93M-99.72M-6.09M-21.03M19.19M-23.59M-24.12M20.66M15.59M23.89M-2.02M29.39M76.75M25.96M
Investing Cash Flow-----5.46M4.56M9.45M-10.10M-7.05M9.07M4.52M3.39M-12.60M13.89M-16.28M-1.06M610.00K-166.21M-1.90M-1.46M-594.00K1.42M-8.47M
Financing Cash Flow339.60M1.48M4.14M8.28M-403.00K-548.00K191.88M3.57M-13.00K-103.94M-21.51M-6.65M-6.50M-40.36M686.00K2.42M2.13M2.65M2.65M-2.78M360.19M-33.98M-51.34M-56.28M-43.82M-72.44M
Capital Expenditure1.47M1.50M3.89M381.00K429.00K2.10M1.58M3.14M1.98M643.00K18.60M3.72M1.31M1.16M956.00K14.93M22.10M18.59M2.19M1.24M1.60M3.70M3.61M11.39M11.45M20.70M
Free Cash Flow---54.79M-70.89M-50.68M-72.64M64.74M-98.80M-61.66M316.80M-3.00M-38.19M-56.24M-100.88M-7.04M-35.97M-2.91M-42.18M-26.31M19.42M13.98M20.18M-5.63M18.00M65.30M5.25M
Dividends Paid---------87.95M---42.48M------------
FCF to OCF--107.64%100.54%100.85%102.98%97.61%103.28%103.32%99.80%-19.26%110.79%102.38%101.16%115.70%171.00%-15.16%178.79%109.07%94.01%89.70%84.50%278.84%61.24%85.09%20.24%
Dividend Paid to FCF---------27.76%----42.11%------------

Earnings

Report DateOct 20, 2004Feb 24, 2005Oct 28, 2005Feb 28, 2006Oct 27, 2006Feb 28, 2007Oct 26, 2007Feb 28, 2008Apr 23, 2008Aug 15, 2008Oct 24, 2008Feb 27, 2009Apr 30, 2009Aug 13, 2009Oct 28, 2009Feb 19, 2010Apr 28, 2010Aug 19, 2010Oct 27, 2010Feb 17, 2011Apr 28, 2011Aug 18, 2011Oct 26, 2011Feb 16, 2012Apr 26, 2012Aug 24, 2012Oct 26, 2012Feb 28, 2013Apr 25, 2013Aug 21, 2013Oct 23, 2013Feb 26, 2014May 7, 2014Aug 26, 2014Nov 6, 2014Feb 12, 2015Apr 28, 2015Aug 13, 2015Oct 28, 2015Feb 10, 2016May 10, 2016Aug 23, 2016Nov 16, 2016Feb 15, 2017May 23, 2017Aug 23, 2017Nov 8, 2017Feb 27, 2018May 23, 2018Aug 8, 2018Nov 8, 2018Feb 27, 2019May 14, 2019Aug 7, 2019Nov 6, 2019Feb 26, 2020May 7, 2020Aug 18, 2020Nov 9, 2020Mar 2, 2021May 19, 2021Aug 11, 2021Nov 16, 2021Feb 23, 2022May 11, 2022Aug 10, 2022Nov 2, 2022Feb 23, 2023May 10, 2023Aug 9, 2023Nov 8, 2023Feb 21, 2024May 15, 2024Aug 7, 2024Nov 13, 2024Feb 19, 2025May 8, 2025Jul 30, 2025Oct 29, 2025Feb 18, 2026May 7, 2026Jul 29, 2026Oct 28, 2026
EPS Estimate0.49-0.83-0.65-0.591.602.56-0.77-1.00---0.93-0.56--15.11-0.72---0.79-0.36---0.54--0.78-0.96---0.94-0.88--0.50-------0.18-0.16-0.19-0.15-0.27-0.12-0.13-0.21-0.41-0.63-0.44-0.30--0.26-0.34-0.15-0.21-0.05--0.56-0.78-0.190.140.08-0.29-0.41-0.48-0.39-0.28-0.26-0.59-0.21-0.40-0.28-0.240.19-0.27-0.17-0.11-0.12-0.07-0.29---
EPS Actual0.78-0.95-0.27-0.75-0.612.47-1.07-0.74-0.91-1.04-0.55-0.42-0.39-0.5516.08-1.01-0.632.72-0.52-0.78-0.75-0.87-0.321.56-0.54-0.65-1.200.16-1.01-0.52-0.62-0.43-0.61-0.201.13-1.10-0.51-0.51-0.23-0.34-0.030.840.000.83-0.18-0.22-0.47-0.60-0.14-0.18-0.22-0.50-0.23-0.24-0.031.95-0.81-0.37-0.110.470.57-0.40-0.27-1.05-0.82-0.68-0.37-0.79-0.430.16-0.180.46-0.290.45-0.13-0.21-0.090.180.15-0.303.12-0.03-
Surprise59.18%-14.46%58.46%-27.12%-138.13%-3.52%-38.96%26.00%--40.86%25.00%--6.42%-40.28%--34.18%-116.67%--40.74%-30.77%32.29%---7.45%40.91%-14.00%-------27.78%-112.50%84.21%660.00%100.96%791.67%-38.46%-4.76%-14.63%4.76%68.18%40.00%--92.31%32.35%-60.00%85.71%4000.00%-33.93%85.90%347.37%307.14%-600.00%6.90%-156.10%-70.83%-74.36%-32.14%-203.85%27.12%176.19%55.00%264.29%-20.83%136.84%51.85%-23.53%18.18%250.00%314.29%-3.45%---
TimingPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market--Pre-marketPre-market--Pre-marketPre-market--Pre-marketPre-market--Pre-market-Pre-marketPre-market--Pre-marketAfter-hours-After-hours-Pre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hours--After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap1.29B
Enterprise Value1.17B
Trailing P/E16.53
Forward P/E121.95
PEG Ratio14.90
Price / Sales1.91
Price / Book2.30
EPS2.91
Book Value22.54
Revenue (TTM)678.72M
Gross Profit (TTM)635.20M
EBITDA129.70M
Profit Margin11.60%
Operating Margin-6.59%
Return on Equity14.49%
Return on Assets8.56%
Shares Outstanding26.92M
Shares Float20.33M
Beta0.32
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20131×
2.00May 23, 2013
20091×
4.00Nov 26, 2009

Stock Splits

  • Jan 25, 2006515:504